The advantages of glucagon-like peptide-1 (GLP-1) medicines beyond glycemic and weight control.
FDA-approved drug could revolutionize organ transplantation
Researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University report that they were able to successfully put tadpoles of Xenopus laevis frogs